课题基金 / 基金详情

CHANGES IN THE ACTIVITIES OF VOLUME-REGULATORY ION CHANNELS DURING CELL DIFFERENTIATION OF MOUSE B LYMPHOCYTES.

CHANGES IN THE ACTIVITIES OF VOLUME-REGULATORY ION CHANNELS DURING CELL DIFFERENTIATION OF MOUSE B LYMPHOCYTES.
小鼠 B 淋巴细胞分化过程中体积调节离子通道活性的变化。
批准号:
62480102
负责人:
OKADA Yasunobu
金额:
$3.46万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1987
资助国家:
日本
项目状态:
已结题
起止时间:
1987 至 1988

项目摘要

项目成果

OKADA Yasunobu的其他基金

相似基金

相关文献

中文摘要
翻译
包括T淋巴细胞在内的多种细胞在KC1外溢引起的初始渗透性肿胀后,可以在低渗介质中重新调节其体积。然而,在成熟的人B淋巴细胞中未发现调节体积减少(RVD) (Grinstein, 1983)。支持这一观察,我们发现成熟的小鼠B细胞系(DW 101)在低渗条件下几乎没有体积调节能力。此外,小鼠b前细胞系(dw34、dw8和abelson白血病病毒转化的b前细胞系)在几十分钟内也未出现RVD。相比之下,pre-pre-B细胞系(scid7, abelson病毒转化的pre-pre-B)在低渗胁迫下可以表现出快速的体积调节。升高细胞外K^+浓度可抑制RVD,降低细胞外C1^-通道阻滞剂(sit)可抑制pre-pre-B细胞的RVD。当加入阳离子离子载体(gramicidine)时,在低na ^+条件下,在低压肿胀的前b细胞中观察到RVD。因此,我们认为RVD机制(可能是K^+转运蛋白)在小鼠b系细胞分化的前b阶段受到损害。事实上,贴片电极的全细胞记录显示,在低渗刺激下,Abelson pre-pre-B细胞系中的K^+和C1^-电流都被激活,但在低渗应激后,pre-B细胞系中只有后者通道被激活。
英文摘要
A variety of cell species, including T lymphocytes, can readjust their volume in a hypotonic medium after the initial osmotic swelling due to KC1 effluxes. However, no regulatory volume decrease (RVD) has been found in mature human B lymphocytes (Grinstein, 1983). Supporting this observation, we found that a mature murine B cell line (DW 101) has little ability of the volume regulation under hypotonic conditions. In addition, mouse pre-B cell lines (DW 34, DW 8 and an abelson leukemia virustransformed pre-B cell line) were also found to exhibit no RVD within several tens ofminutes. In contrast, pre-pre-B cell lines (SCID 7, abelson virus-transformed pre-pre-B) could show rapid volume regulation upon hypotonic stress. The RVD was suppressed by elevating the extracellular K^+ concentration and facilitated by reducing the extracellular C1^- channel blocker (SITS) inhibited the RVD of pre-pre-B cells. When a cationic ionophore (gramicidine) was added, the RVD was observed i n hypotonically swollen pre-B cells under the low-Na^+ condition. Thus, it is suggested that the RVD mechanism (presumably K^+ transporters) becomes impaired during the mouse B-lineage cell differentiation at the pre-B stage. In fact, whole-cell recordings with patch electrodes showed that both K^+ and C1^- currents became activated in an Abelson pre-pre-B cell line upon a hypotonic challenge, but that only the latter channel was activated in the pre-B cell line after hypotonic stress.
期刊论文(28)
专著(0)
科研奖励(0)
会议论文
挾間章博: Journal of Physiology. 402. 687-702 (1988)
波萨明宏:生理学杂志 402. 687-702 (1988)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
岡田泰伸: News in Physiological Sciences. (1989)
冈田康信:生理科学新闻(1989)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 14 条
    Mechanisms of interaction between the volume-sensitive outwardly rectifying anion channel, VSOR, and a novel membrane protein, LRRC8A.
    • 批准号:
      15K15028
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2015
    • 负责人:
      OKADA Yasunobu
    • 依托单位:
    Elucidation of hypotonicity-induced suppression mechanism of vasopressin secretion through identification of hypoosmolarity sensor
    • 批准号:
      23659118
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2011
    • 负责人:
      OKADA Yasunobu
    • 依托单位:
    Molecular characterization of volume-activated anion channels and elucidation of cell death-survival switching mechanisms
    国内基金
    海外基金
    Foxc2介导Syap1/Akt信号通路调控破骨/成骨细胞分化促进颞下颌关节骨关节炎的机制研究
    • 批准号:
      82370979
    • 项目类别:
      面上项目
    • 资助金额:
      48.00万元
    • 批准年份:
      2023
    • 负责人:
      张善勇
    • 依托单位:
    BRD4通过结合TEAD1调控β细胞增殖分化的机制研究
    • 批准号:
      82370801
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      李峰
    • 依托单位:
    22q11.2染色体微重复影响TOP3B表达并导致腭裂发生的机制研究
    • 批准号:
      82370906
    • 项目类别:
      面上项目
    • 资助金额:
      48.00万元
    • 批准年份:
      2023
    • 负责人:
      代杰文
    • 依托单位:
    新生儿坏死性小肠结肠炎中去泛素化酶USP15调控ILC3分化损伤肠道粘膜屏障的致病机制研究
    • 批准号:
      82371711
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      吕志宝
    • 依托单位: